List of Acronyms. National Institutes of Health Offices, Institutes, and Centers
|
|
- Prosper Bond
- 6 years ago
- Views:
Transcription
1 List of Acronyms National Institutes of Health Offices, Institutes, and Centers Offices: OD Office of the Director Institutes: NCI NEI NHGRI NHLBI NIA NIAAA NIAID NIAMS NIBIB NICHD NIDA NIDCD NIDCR NIDDK NIEHS NIGMS NIMH NINDS NINR NLM National Cancer Institute National Eye Institute National Human Genome Research Institute National Heart, Lung, and Blood Institute National Institute on Aging National Institute on Alcohol Abuse and Alcoholism National Institute of Allergy and Infectious Diseases National Institute of Arthritis and Musculoskeletal and Skin Diseases National Institute of Biomedical Imaging and Bioengineering National Institute of Child Health and Human Development National Institute on Drug Abuse National Institute on Deafness and Other Communication Disorders National Institute of Dental and Craniofacial Research National Institute of Diabetes and Digestive and Kidney Diseases National Institute of Environmental Health Sciences National Institute of General Medical Sciences National Institute of Mental Health National Institute of Neurological Disorders and Stroke National Institute of Nursing Research National Library of Medicine 1
2 Centers: CC CIT CSR FIC NCCAM NCMHD NCRR Clinical Center Center for Information Technology Center for Scientific Review Fogarty International Center National Center for Complementary and Alternative Medicine National Center on Minority Health and Health Disparities National Center for Research Resources Components of the Office of Portfolio Analysis and Strategic Initiatives Divisions: DESA DRDA DSC Division of Evaluation and Systematic Assessments Division of Resource Development and Analysis Division of Strategic Coordination DESA Branches: EB SAB Evaluation Branch Systemic Assessments Branch DRDA Branches: DTA PASO PHB Data, Tools, & Analysis Branch Portfolio Analysis & Scientific Opportunities Branch Public Health Burden Branch DSC Branches: AB OB Analysis Branch Operations Branch Division of Program Coordination, Planning, and Strategic Initiatives OAR OBSSR ODP Office of AIDS Research Office of Behavioral and Social Sciences Research Office of Disease Prevention 2
3 ODS OMAR ORD ORWH Office of Dietary Supplements (within ODP) Office of Medical Applications of Research (within ODP) Office of Rare Diseases (within ODP) Office of Research on Women s Health NIH Activity Codes [new section] Activity Codes are a three-digit code assigned by NIH to identify funding mechanisms (e.g., F32, K12, P01, R01, T32, etc.) General categories include the following: D training projects (e.g., NIH Director s Pioneer Award; NIH Director s New Innovator Awards) F -- fellowships K -- career development awards L loans and scholarships N research contracts P program project and research center grants R research project grants S research-related programs T training grants U cooperative agreements X formula grants Y interagency agreements Z intramural research For specific activity codes and definitions, go to IMPAC Activity Codes, Organization Codes, and Definitions Used in Extramural Programs (Tables 2-4). Also see the Types of Grant Programs page to search activity codes and for more information on selected grant programs, including trans-nih programs. Useful URLs re Activity Codes: NIH Activity Codes: go to bottom of page and click on Activity Codes: For alphabetical comprehensive list: For grants glossary and acronyms: 3
4 Additional Terms from November 8, 2007, and March 31-April 1, 2008, Slide Presentations Note: New entries are in bold font. Items in parens (e,g,, Porter slide 16) note where acronym appears. AACR American Association for Cancer Research (Porter slide 16) AAMC AC ACD ADHD ADMET AHRQ ALS AREDS ATTC BECON Association of American Medical Colleges Advisory Council (each IC has an Advisory Council) Advisory Committee to the Director (NIH) attention deficit hyperactivity disorder adaptation, distribution, metabolism, excretion (ADME) and toxicological (TOX) profiles; sometimes listed as ADME/Toxicology (Collins slide 7) Agency for Healthcare Research and Quality amyotrophic lateral sclerosis (also known as Lou Gehrig s disease) Age-Related Eye Disease Study (NEI macular degeneration study) a private, nonprofit biological resource center, based at Georgetown University, Washington, D.C. ( (DSC Subcommittee summary) Bioengineering Consortium BIO Biotechnology Industry Organization (Porter slide 14) BISTI Biomedical Information Science and Technology Initiative BRDPI Biomedical Research and Development Price Index (Hays slide 5) CaPS CAT CBT CDC CF CMS CoC COPR CTSA cleaved amplified polymorphic sequences computer adaptive testing (technology used by PROMIS) [see computer-based testing (technology used by PROMIS) Centers for Disease Control and Prevention (within DHHS) Common Fund (established by NIH Reform Act of 2006 to support trans-nih initiatives) Centers for Medicare & Medicaid Services Council of Councils Council of Public Representatives Clinical and Translational Science Awards 4
5 DARPA dbgap DCCT DESA DHHS DoD DOE DOG DPCPSI DRDA DSC EDIC egfp EPMC FDA FNIH Defense Advanced Research Projects Agency (high-risk program group within DoD) database of Genotypes and Phenotypes Diabetes Control and Complications Trial (sponsored by NIDDK) Division of Evaluation and Systematic Assessments (within OPASI) U.S. Department of Health and Human Services (NIH is an agency within DHHS; also listed as HHS) U.S. Department of Defense (also DOD) U.S. Department of Energy Demonstration Oversight Group(s) Division of Program Coordination, Planning, and Strategic Initiatives (an assembly of cooperating offices within OD to perform the named functions for trans-nih research supported by the Common Fund) Division of Resource Development and Analysis (within OPASI) Division of Strategic Coordination (within OPASI) Epidemiology of Diabetes Interventions and Complications Study (sponsored by NIDDK)] enhanced green fluorescent protein (Collins slide 21) (also see GFP) Extramural Scientific Program Management Committee U.S. Food and Drug Administration (within DHHS) Foundation for the National Institutes of Health FY fiscal year (e.g., FY 2009, which is October 1, 2008, through September 30, 2009) GAIN Genetic Association Information Network [ GEI GFP GeneLink GoKind Genes and Environment Initiative (sponsored by NHGRI) green fluorescent protein (Collins slide 21) (also see egfp) a data management system developed by NHGRI to facilitate genetic studies of complex traits Genetics of Kidneys in Diabetes Study (sponsored by NCRR and Juvenile Diabetes Research Foundation) GPCRs G protein-coupled receptors; targets of many modern medicinal drugs (Collins slide 9) GPRA Government Performance and Results Act of 1993 GSK GlaxoSmithKline (Porter slide 15) 5
6 GWAS HAQ HHS HIPPA genome-wide association studies Health Assessment Questionnaire U.S. Department of Health and Human Services (NIH is within HHS) (also listed as DHHS) Health Insurance Portability and Accountability Act HTS high-throughput screening (Collins slide 5 IADL IC ICDs ICOD IMPAC Internet Access to Digital Libraries Institute or Center (NIH) NIH Institute, Center, or Division A rotating group of three IC Directors and the OPASI Director; the group is delegated the responsibility of deciding programmatic details (i.e., approving RFAs and Funding Plans) and other issues as they arise Information for Management, Planning, Analysis, and Coordination IP intellectual property (Mittleman slide 18) IR IRB IRIG IRT IT LEAPS LIAPs MESA intramural research; also interdisciplinary research Institutional Review Board Interdisciplinary Research Implementation Group (part of a Roadmap initiative) (Tabak) item-response theory (technology used by PROMIS) information technology Locomotor Experience Applied Post Stroke Trial (sponsored by NINDS and MJFF) Legislative Implementation Action Plan Multi-Ethnic Study of Atherosclerosis (sponsored by NHLBI) MICAD Molecular Imaging and Contrast Agent Database (Collins slide 7) MOU memorandum of understanding (Mittleman slide 5) MJFF Michael J. Fox Foundation (sponsor of LEAPS) MLI Molecular Libraries Implementation and Imaging Initiative ( (a Roadmap initiative) MLSC MLSCN Molecular Libraries Screening Center (Collins re MLI) Molecular Libraries Screening Center Network (Collins re MLI) MLSMR Molecular Libraries Small Molecule Repository (Collins slide 7) NAS National Academy of Sciences 6
7 NCBI NCGC NCHS NIH NLM NRSA NSF OAR OB OBSSR OCPL OD ODP ODS OER OGC OIR OLPA OM OMAR OMB OPASI ORD ORWH OSP OTT PA National Center for Biotechnology Information (within NLM) NIH Chemical Genomics Center (Collins re Molecular Libraries Screening Center Network [MLSCN]) National Center for Health Statistics (Hays) National Institutes of Health National Library of Medicine National Research Service Award National Science Foundation Office of AIDS Research (an OD Program Office, part of DPCPSI) Office of Budget (within OD) Office of Behavioral and Social Sciences Research (an OD Program Office, part of DPCPSI) Office of Communication and Public Liaison (within OD) Office of the Director (NIH) Office of Disease Prevention (an OD Program Office, part of DPCPSI) Office of Dietary Supplements (within ODP) Office of Extramural Research (within OD) Office of the General Counsel (within OD) Office of Intramural Research (within OD) Office of Legislative Policy and Analysis (within OD) Office of Management (within OD, NIH) Office of Medical Applications of Research (within ODP) Office of Management and Budget (within the U.S. Executive Branch) Office of Portfolio Analysis and Strategic Initiatives Office of Rare Diseases (within ODP) Office of Research on Women s Health (an OD Program Office) Office of Science Policy (within OD, NIH) Office of Technology Transfer (within OD, NIH) Program Announcement (an NIH announcement requesting grant applications in stated scientific areas) 7
8 PAR PART Program Announcement with a special receipt, referral, and/or review consideration as described in the PA (Duran) Program Assessment Rating Tool (OMB) (also used for Program Assessment Performance Tool and for Programmatic Assessment Review Tool]) PhRMA Pharmaceutical Research and Manufacturers of America (Porter slide 14) PHS PI PORT PPP PRG PROMIS PROs Public Health Service Principal Investigator Portfolio On-Line Reporting Tool public-private partnerships ( (Mittleman) NCI Progress Review Group; using NCI's current research program as a baseline, a PRG identifies priority areas for research (Porter slide 16) Patient-Reported Outcomes Measurement Information System (an NIH Roadmap initiative) patient-reported outcomes PubChem database of chemical molecules, maintained by NCBI; provides information on biological activities of small molecules ( (Collins) QIR RAID R01 RCDC R&D RFA RFI RM RPG PIs SBIR SE SEP SHARe sirna qualitative item review (process used by PROMIS) Rapid Access to Intervention Development (Wilder) NIH grant funding mechanism for investigator-initiated research Research, Condition and Disease Categorization] research and development Request for Application (NIH grant application mechanism) Request for Information NIH Roadmap Research Project Grant Principal Investigators Small Business Innovation and Research grant Standard error Special Emphasis Panel Framingham SNP Health Association Resource (extensive database of genetic and clinical data from the Framingham Heart Study sponsored by NHLBI) silencing RNA; also called small interfering RNA or short interfering RNA; most notably, sirna interferes with the expression of a specific gene (Collins) 8
9 SMRB SNP STTR T5 Scientific Management Review Board (established by Reform Act of 2006 to advise NIH Director and conduct organizational reviews of NIH every 7 years) single nucleotide polymorphisms (genetic variations; see SHARe) Small Business Technology Transfer noncompeting continuation application TAC NIH Training Advisory Committee (Tabak slide 39) TBD UMLS to be determined Unified Medical Language System VRC Dale and Betty Bumpers Vaccine Research Center (within NIAID) (Porter Slide 14) WG WHO working group World Health Organization 9
Christopher P. Austin, M.D. Director, NCATS IOM CTSA Review Committee January 24, 2013
Christopher P. Austin, M.D. Director, NCATS IOM CTSA Review Committee January 24, 2013 Basic Laboratory Research Clinical Research Improved Public Health Translational Research Population Research Basic
More informationLili M. Portilla, MPA Acting Director, Office of Policy, Communications and Strategic Alliances National Center for Advancing Translational Sciences
Lili M. Portilla, MPA Acting Director, Office of Policy, Communications and Strategic Alliances National Center for Advancing Translational Sciences (NCATS), NIH GUIRR Meeting, October 9, 2012 Established
More informationRare Diseases: Challenges and Opportunities NIH Perspective
Rare Diseases: Challenges and Opportunities NIH Perspective Stephen C. Groft, Pharm.D. Office of Rare Diseases Research (ORDR) National Center for Advancing Translational Science (NCATS) National Institutes
More informationNon-Dilutive Funding For Clinical Stage R&D
FreeMindGroup FreeMind Group @FreeMindGrp Non-Dilutive Funding For Clinical Stage R&D Meytal Waiss Director, Business Development FreeMind Group The Global Non-Dilutive Funding Leader FreeMind Group, LLC
More informationSMALL BUSINESS INNOVATION RESEARCH (SBIR) SMALL BUSINESS TECHNOLOGY TRANSFER (STTR) GRANT APPLICATIONS
U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES PHS 2018-2 OMNIBUS SOLICITATION OF THE NATIONAL INSTITUTES OF HEALTH, CENTERS FOR DISEASE CONTROL AND PREVENTION, AND FOOD AND DRUG ADMINISTRATION FOR SMALL
More informationDr. Krishna Balki Balakrishnan Senior Technology Manager, Office of Strategic Alliances National Center for Advancing Translational Sciences, NIH
Dr. Krishna Balki Balakrishnan Senior Technology Manager, Office of Strategic Alliances National Center for Advancing Translational Sciences, NIH Email: Balki@nih.gov Established on December 23, 2011 Part
More informationLili M. Portilla, MPA Acting Director, Office of Policy, Communications and Strategic Alliances National Center for Advancing Translational Sciences
Lili M. Portilla, MPA Acting Director, Office of Policy, Communications and Strategic Alliances National Center for Advancing Translational Sciences (NCATS), NIH Email: Lili.Portilla@nih.gov Established
More informationThe Impact of National Institutes of Health Funding on U.S. Cardiovascular Disease Research
The Impact of National Institutes of Health Funding on U.S. Cardiovascular Disease Research Radmila Lyubarova 1, Brandon K. Itagaki 2,3, Michael W. Itagaki 4 * 1 Division of Cardiology, Department of Medicine,
More informationTHE IMPACT OF THE AFFORDABLE CARE ACT (ACA) ON CANCER RESEARCH, CARE, AND PREVENTION
THE IMPACT OF THE AFFORDABLE CARE ACT (ACA) ON CANCER RESEARCH, CARE, AND PREVENTION William S. Dalton, PhD, MD AACR April 17, 2016 Designing a Federated Model To Support Research & Healthcare Offices
More informationNewsletter. funding opportunities for research. Alcohol, Drugs or Abuse &/or Smoking. Bioimaging and Radiation Research
Newsletter funding opportunities for research Announcements Alcohol, Drugs or Abuse &/or Smoking Bioimaging and Radiation Research Bioinformatics Biomedical Technology Cancer & Blood Complementary & Alternative
More informationHRPP Policy No. 714 Effective Date 09/01/10 Revisions Date. Genome Wide Association Studies
Genome Wide Association Studies HRPP Policy No. 714 Effective Date 09/01/10 Revisions Date 1.0 Purpose This policy describes how investigators at the University of South Florida (USF) and USF Affiliates
More informationCollaborative Rare Diseases Research Activities at NIH
Collaborative Rare Diseases Research Activities at NIH Christopher P. Austin, M.D. Director National Center for Advancing Translational Sciences IRDiRC April 16, 2013 Background ~ 18 25 million people
More informationNeuroscience at NIH. NINDS, NIMH, NIDA, NIA, NICHD, NEI, NIDCD, NIAAA Each has its own disease mission All fund basic science
Neuroscience at NIH NIH s mission is to seek fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to enhance health, lengthen life, and reduce the
More informationTechnology Development Funding Program Round 3
Technology Development Funding Program Round 3 CWRU January 26, 2015 1 Program Overview NIH Center for Accelerated Innovations (NCAI) at Cleveland Clinic Mission to improve translation of basic science
More informationPresentation to the Committee on Accelerating Rare Disease Research and Orphan Product Development
Presentation to the Committee on Accelerating Rare Disease Research and Orphan Product Development 23 November 2009 Sharon F. Terry, MA President & CEO, Genetic Alliance Executive Director, PXE International
More informationRequest for Projects for Wake Forest Brain Tumor SPORE Application
1 Request for Projects for Wake Forest Brain Tumor SPORE Application This RFA is for three types of projects that will be taken into consideration for inclusion in the Wake Forest Brain Tumor Specialized
More informationGenomic Research: Issues to Consider. IRB Brown Bag August 28, 2014 Sharon Aufox, MS, LGC
Genomic Research: Issues to Consider IRB Brown Bag August 28, 2014 Sharon Aufox, MS, LGC Outline Key genomic terms and concepts Issues in genomic research Consent models Types of findings Returning results
More informationBuilding on the NHLBI Legacy of Hypertension Research:
Building on the NHLBI Legacy of Hypertension Research: Charting Our Future Together Gary H. Gibbons, M.D. Director National Heart, Lung, and Blood Institute AHA Council on Hypertension September 16, 2015
More informationResearch Opportunities at NIGMS. Stephen Marcus, Ph.D.
Research Opportunities at NIGMS Stephen Marcus, Ph.D. Mission Statement of the NIGMS The National Institute of General Medical Sciences supports basic research that increases understanding of biological
More informationFood, Nutrition, Agriculture, and Natural Resource Sciences in the FY 2014 Budget
27 Food, Nutrition, Agriculture, and Natural Resource Sciences in the FY 2014 Budget William Fisher Institute of Food Technologists Sarah Ohlhorst American Society for Nutrition Karl Anderson and Karl
More informationInCHIP Research Interest Groups Crystal.park@uconn.edu Debbie Cornman @ Deborah.cornman@uconn.edu Debarchana.ghosh@uconn.edu HIV Research Interest Group - Chaired by Seth Kalichman @ Seth.K@uconn.edu Amy.gorin@ucponn.edu
More informationClinicalTrials.gov Registration Guide
ClinicalTrials.gov Registration Guide The Food and Drug Administration Amendments Act (FDAAA), National Institutes of Health (NIH) and International Committee of Medical Journal Editors (ICMJE) require
More informationLessons from the Human Genome Project that may be applicable to the Exposome Endeavor
Lessons from the Human Genome Project that may be applicable to the Exposome Endeavor Christopher P. Austin. M.D. Director, NIH Chemical Genomics Center Senior Advisor to the NHGRI Director for Translational
More informationOpportunities for industry/smes in EU-funded health research
Opportunities for industry/smes in EU-funded health research Stéphane Hogan, M.Sc, MBA Head of Unit Applied Genomics and Biotechnology for Health DG Research - European Commission 1 Paris, 31 May 2005
More informationLOINC in Regulated Clinical Research a Lab LOINC Steeringg Committee Meeting 08 June 2017
LOINC in Regulated Clinical Research a Lab LOINC Steeringg Committee Meeting 08 June 2017 Lauren Becnel, Ph.D. VP, Biomedical Informatics & Alliances, CDISC Asst Prof, Duncan Comprehensive Cancer Center,
More informationCONNECTICUT. Bioscience Performance Metrics. Connecticut Page 1
CONNECTICUT Connecticut has a specialized and diverse concentration of employment in the overall bioscience industry and in two of its subsectors: drugs and pharmaceuticals (location quotient of 2.01)
More informationRESEARCH INTEGRITY AND THE NIH
RESEARCH INTEGRITY AND THE NIH NOVEMBER 9, 2017 PATRICIA VALDEZ, Ph.D. NIH EXTRAMURAL RESEARCH INTEGRITY OFFICER Important Goal of the NIH To exemplify and promote the highest level of scientific integrity,
More informationMARYLAND. Bioscience Performance Metrics. Maryland Page 1
MARYLAND Maryland is home to a specialized and rapidly growing bioscience industry. The State s largest bioscience subsector, research, testing and medical laboratories is also its most specialized in
More informationIOWA. Bioscience Performance Metrics. Iowa Page 1
IOWA Iowa has a highly concentrated and rapidly growing bioscience industry. Iowa has nearly 7 percent of national employment, faster growth than the national average, and a highly specialized concentration
More informationVERMONT. Bioscience Performance Metrics. Vermont Page 1
VERMONT Vermont has developed a specialized employment concentration in medical devices and equipment (location quotient of 1.43). The State s $97 million in academic bioscience research and development
More informationPharmacogenomics and Health Policy
Pharmacogenomics and Health Policy Amalia M. Issa, PhD, MPH Founding Director, Program in Personalized Medicine & Targeted Therapeutics Professor and Chair Department of Health Policy and Public Health
More informationICH Topic E15 Definitions for genomic biomarkers, pharmacogenomics, pharmacogenetics, genomic data and sample coding categories.
European Medicines Agency November 2007 EMEA/CHMP/ICH/437986/2006 ICH Topic E15 Definitions for genomic biomarkers, pharmacogenomics, pharmacogenetics, genomic data and sample coding categories Step 5
More informationRelated Donor Informed Consent to Participate in Research
Related Donor Informed Consent to Participate in Research This is an informed consent document for a research study that your family member is participating in. This document will inform you about the
More informationSSPPS STRATEGIC PLAN. Pharmacy Education, Pharmaceutical Sciences Research, Clinical Pharmacy Practice. April 30, Overview
SSPPS STRATEGIC PLAN Pharmacy Education, Pharmaceutical Sciences Research, Clinical Pharmacy Practice April 30, 2012 Overview Here we present the 2012-2017 strategic plan for the Skaggs School of Pharmacy
More informationCase Study: University of Washington s Clinical Research Billing Audit Program
Case Study: University of Washington s Clinical Research Billing Audit Program 7 th Annual Conference for Effective Compliance Systems in Higher Education Richard A. Meeks, CCEP Agenda Background Probe
More informationSummary of Provisions in 21 st Century Cures Act (H.R. 6) as passed by full House of Representatives, July 10, 2015
Pediatric-Specific Provisions Summary of Provisions in 21 st Century Cures Act (H.R. 6) as passed by full House of Representatives, July 10, 2015 Requires the NIH to complete a strategic plan, and in the
More informationRHODE ISLAND. Bioscience Performance Metrics. Rhode Island Page 1
RHODE ISLAND Rhode Island has a specialized employment concentration in two growing bioscience industry subsectors drugs and pharmaceuticals (location quotient of 1.) and medical devices and equipment
More informationOverview of Health Informatics. ITI BMI-Dept
Overview of Health Informatics ITI BMI-Dept Fellowship Week 5 Overview of Health Informatics ITI, BMI-Dept Day 10 7/5/2010 2 Agenda 1-Bioinformatics Definitions 2-System Biology 3-Bioinformatics vs Computational
More informationNIH PUBLIC ACCESS POLICY and MyNCBI
NIH PUBLIC ACCESS POLICY and MyNCBI Matty Gilreath and Valerie Pascual, Research Management Services, Team E (Adapted from an original presentation by Christine Razler, Director of Research Administration,
More informationPersonalized. Health in Canada
Personalized Health in Canada Canadian Institutes of Health Research Personalized Medicine Signature Initiative 2010-2013 0 Dr. Morag Park CIHR Institute of Cancer Research Dr. Paul Lasko CIHR Institute
More informationWebinar Tips Please mute your phone. Please do not put the call on hold. There will be time for questions after the presentation.
Webinar Tips Please mute your phone. Please do not put the call on hold. There will be time for questions after the presentation. Carolinas Collaborative Pilot RFA Webinar May 8, 2017 Partners Overview
More informationThe 100,000 Genomes Project Genomics Collaboration Event Finnish Residence
The 100,000 Genomes Project Genomics Collaboration Event Finnish Residence Prof Mark Caulfield FMedSci Chief Scientist for Genomics England Barts Heart Centre William Harvey Research Institute Queen Mary
More informationISPE Comments on the CIOMS 2006 draft Special Ethical Considerations for Epidemiologic Research 1
Epidemiologic Research 1 December 12, 2006 Comments on 2006 CIOMS draft Special Ethical Considerations for Epidemiologic Research as proposed supplement to the updated 2002 CIOMS International Ethical
More informationHuman Subjects Protection: Training for Research Teams
Human Subjects Protection: Training for Research Teams Walter L. Calmbach MD MPH South Texas Ambulatory Research Network (STARNet) Dept. of Family & Community Medicine Univ. of Texas Health Science Center
More informationInnovating out of Crisis
Innovating out of Crisis Shigetaka Komori Chairman and CEO FUJIFILM Holdings Corporation 1 st June, 2015 Business Fields of Fujifilm Group Digital Camera Photo book Optical devise FY2015/3 Digital minilab
More informationGene-Environment Interactions In Complex Human Diseases
Gene-Environment Interactions In Complex Human Diseases Xiaobin Wang, MD, MPH, ScD Director and The Mary Ann & J. Milburn Smith Research Professor The Mary Ann & J. Milburn Smith Child Health Research
More informationUK Biobank Axiom Array
DATA SHEET Advancing human health studies with powerful genotyping technology Array highlights The Applied Biosystems UK Biobank Axiom Array is a powerful array for translational research. Designed using
More informationPLTW Biomedical Science Medical Interventions Course Outline
Follow the fictitious Smith family as you learn about the prevention, diagnosis, and treatment of disease. Play the role of biomedical professionals to analyze case information and diagnose and treat your
More informationSingHealth and A*STAR to advance medical research in diabetes; immunotherapy and drug development; and precision medicine
MEDIA RELEASE SingHealth and A*STAR to advance medical research in diabetes; immunotherapy and drug development; and precision medicine Strategic partnership sees Singapore s largest public healthcare
More informationProduction Assistance for Cellular Therapies PACT
Production Assistance for Cellular Therapies PACT Traci Heath Mondoro, PhD NHLBI Bethesda, Maryland Renewed PACT Program Renewed January 15, 2010 Scope and size expanded Cell Processing Facilities (CPFs)
More informationNIH Blueprint for Neurotherapeutics: A novel approach to early stage drug discovery research funding
U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Neurological Disorders and Stroke NIH Blueprint for Neurotherapeutics: A novel approach to early stage drug
More informationIRDiRC: International Rare Diseases Research Consortium
IRDiRC: International Rare Diseases Research Consortium EuRenomics, NEUROMICS and RD-Connect Joint Kick-off Meeting Sitges, Spain, 25 January 2013 Dr. Iiro Eerola Scientific Project Officer Unit for Personalised
More informationGUIDANCE ON THE EVALUATION OF NON ACCREDITED QUALIFICATIONS
GUIDANCE ON THE EVALUATION OF NON ACCREDITED QUALIFICATIONS 1. Introduction 1.1 This document provides guidance notes for the assessment of academic qualifications that have not been formally accredited
More informationPOLICY AND PROCEDURE MANUAL
POLICY AND PROCEDURE MANUAL PBRC: POLICY NO. 378.00 ORIGIN DATE: 5/25/2016 IMPACTS: CLINICAL RESEARCH LAST REVISED: 1/1/2017 SUBJECT: SOURCE: PURPOSE PENNINGTON BIOMEDICAL CLINICALTRIALS.GOV POLICY INSTITUTIONAL
More informationClinical Research at MSU
Financial Administration Development Program: Clinical Research at MSU Kristen Burt, Office of Regulatory Affairs (ORA) Sharon Schooley, Clinical & Translational Sciences Institute (CTSI) February 24,
More informationUVA Biorepository & Tissue Research Facility (BTRF) Coded-Specimens Guidance
Last Modified 09/15/2015 UVA Biorepository & Tissue Research Facility (BTRF) Coded-Specimens Guidance Setting up a new coded-specimens protocol with the IRB is very easy and will allow you to receive coded
More informationemerge-ii site report Vanderbilt
emerge-ii site report Vanderbilt 29 June 2015 Vanderbilt activities emerge II PGx implementation locally and emerge-pgx SCN5A/KCNH2 project provider attitudes Phenotype contributions Methods development
More informationLA RICERCA TELETHON PER LE MALATTIE RARE TELETHON RESEARCH ON RARE DISEASES
LA RICERCA TELETHON PER LE MALATTIE RARE TELETHON RESEARCH ON RARE DISEASES Francesca Pasinelli Direttore Generale 3 Congresso Nazionale SIFaCT Roma, 9 ottobre 2015 About Telethon Fondazione Telethon is
More informationTypes of Databases - By Scope
Biological Databases Bioinformatics Workshop 2009 Chi-Cheng Lin, Ph.D. Department of Computer Science Winona State University clin@winona.edu Biological Databases Data Domains - By Scope - By Level of
More informationNCI Research Networks Model for Collaboration with Bioelectronics Round Table
NCI Research Networks Model for Collaboration with Bioelectronics Round Table Larry Clarke, Cancer Imaging Program DCDT, NCI Detail: NIBIB Guest Scientist: NIST 1 Bioelectronics Round Table Research Triangle
More informationPresented by: Tess L. Crisostomo Laboratory Quality Assurance/Compliance Officer Naval Medical Center San Diego
Presented by: Tess L. Crisostomo Laboratory Quality Assurance/Compliance Officer Naval Medical Center San Diego Discuss the difference between DNA Genotyping and Genome Sequencing What makes you who you
More informationCultural Competence Training Survey - Results
28 Cultural Competence Training Survey - Results Prepared by Anne Turner, MLIS NW Resource Center on CLAS and Health Disparities The Cross Cultural Health Care Program www.culture.org In collaboration
More informationWITA/GWU TRADE SEMINAR September 29, 2016 Washington D.C. RICHARD KJELDGAARD INTELLECTUAL PROPERTY AND TRADE CONSULTANT
WITA/GWU TRADE SEMINAR September 29, 2016 Washington D.C. RICHARD KJELDGAARD INTELLECTUAL PROPERTY AND TRADE CONSULTANT Pharmaceutical IP Policy Issues Economics - Business Model IP TPP Global Challenges
More informationProtection of Research Participants: The IRB Process and the Winds of Change
Protection of Research Participants: The IRB Process and the Winds of Change Ethics in Patient-Oriented Research October 12, 2011 Sharon Friend Director, OHRPP Overview Charge and Function of the IRB Quick
More informationTOTAL CANCER CARE: CREATING PARTNERSHIPS TO ADDRESS PATIENT NEEDS
TOTAL CANCER CARE: CREATING PARTNERSHIPS TO ADDRESS PATIENT NEEDS William S. Dalton, PhD, MD CEO, M2Gen & Director, Personalized Medicine Institute, Moffitt Cancer Center JULY 15, 2013 MOFFITT CANCER CENTER
More informationThe Innovative Medicines Initiative: Building new models of collaborative research across Europe
The Innovative Medicines Initiative: Building new models of collaborative research across Europe Elisabetta Vaudano IMI, Belgium www.imi.europa.eu What is IMI? An European Public-Private Partnership Focused
More informationVALUE-BASED HEALTHCARE A MANUFACTURER S PERSPECTIVE PETER JUHN, MD, MPH VICE PRESIDENT AND GLOBAL HEAD, VALUE-BASED PARTNERSHIPS
VALUE-BASED HEALTHCARE A MANUFACTURER S PERSPECTIVE PETER JUHN, MD, MPH VICE PRESIDENT AND GLOBAL HEAD, VALUE-BASED PARTNERSHIPS NATIONAL CONFERENCE OF STATE LEGISLATURES SAN DIEGO, CA DECEMBER 10, 2017
More informationVice President, Research Senior Vice President & COO, Health Center Operations. Position Summary*:
About Howard Brown Health Center: Howard Brown exists to eliminate the disparities in health care experienced by lesbian, gay, bisexual and transgendered people through research, education and the provision
More informationLearning Objectives. Introduction
Tools for Teaching Genetics in Primary Care Charles J. Macri, MD Leon Moore, Ph.D. NEGEA Baltimore, Maryland 3 March 2001 Learning Objectives Why is genetics an important topic for discussion now? Identify
More informationHolland Innovation Network Team Boston: Walter de Wit Julia Knoeff
Holland Innovation Network Team Boston: Walter de Wit Julia Knoeff Boston and Cambridge in Massachusetts are innovation-focused hubs with world-leading universities such as Harvard, Boston University and
More informationLeveraging an Academic-Industry Partnership for Commercial Success
Leveraging an Academic-Industry Partnership for Commercial Success For 115 Years, the Nation s Leading Respiratory Hospital Respiratory Heritage: 115 Years of Respiratory Research and Care Allergy, Asthma,
More informationBiomedical Big Data and Precision Medicine
Biomedical Big Data and Precision Medicine Jie Yang Department of Mathematics, Statistics, and Computer Science University of Illinois at Chicago October 8, 2015 1 Explosion of Biomedical Data 2 Types
More informationCS273B: Deep Learning in Genomics and Biomedicine. Recitation 1 30/9/2016
CS273B: Deep Learning in Genomics and Biomedicine. Recitation 1 30/9/2016 Topics Genetic variation Population structure Linkage disequilibrium Natural disease variants Genome Wide Association Studies Gene
More informationAge-Adjusted Death Rates for Coronary Heart Disease, U.S.,
Age-Adjusted Death Rates for Coronary Heart Disease, U.S., 1950-2004 Deaths/100,000 Population 600 500 400 300 200 100 Risk Factors U.S. Actual U.S. "Could Be" (Based on Japan Actual) 0 1950 1960 1970
More informationOffice for Human Subject Protection. University of Rochester
POLICY 1. Purpose Outline the responsibilities and regulatory requirements when conducting human subject research that involves the use of drugs, agents, biological products, or nutritional products (e.g.,
More informationGuidelines for 2015 Pilot & Feasibility Grant Applications
Guidelines for 2015 Pilot & Feasibility Grant Applications DESCRIPTION INSTITUTIONAL ELIGIBILITY APPLICANT ELIGIBILITY TERMS PILOT AND FEASIBILITY GRANT The objective of this grant is to provide funds
More informationNordic Register and Biobank Data
Nordic Register and Biobank Data A basis for innovative research on health and welfare Juni Palmgren Karolinska Institutet, Stockholm Nordic conference on Real World Data Helsinki November 2016 Nordic
More informationFDA Oversight of Gene Therapy
FDA Oversight of Gene Therapy Celia M. Witten, Ph.D., M.D. Deputy Director, FDA CBER Rare Disease and Orphan Products Breakthrough Summit NORD October 17, 2016 Hyatt Regency Crystal City Crystal City,
More informationUniversity of Pennsylvania Perelman School of Medicine High Throughput Screening Core
University of Pennsylvania Perelman School of Medicine High Throughput Screening Core Sara Cherry, Ph. D. David C. Schultz, Ph. D. dschultz@mail.med.upenn.edu (215) 573 9641 67 John Morgan Building Mission
More informationMalaria Research Capability Strengthening in Africa
July 2005 UNICEF/UNDP/World Bank/WHO Special Programme for Research & Training in Tropical Diseases (TDR) Multilateral Initiative on Malaria (MIM) Malaria Research Capability Strengthening in Africa INTRODUCTION
More informationUNDERSTANDING GENETIC RESEARCH AND ALTERNATING HEMIPLEGIA OF CHILDHOOD. IT ALL BEGINS WITH THE AHC PATIENT And The Scientific Process
IT ALL BEGINS WITH THE AHC PATIENT And The Scientific Process Genetic discovery AHC Patients Need Help! Researchers collect data on AHC patients (observation) Researchers interpret and evaluate data AHC
More informationThe University of Texas MD Anderson Cancer Center Internal Audit Annual Report for FY 2017
Purpose of the Annual Report The purpose of the internal audit annual report is to provide information on the assurance services, consulting services, and other activities of the internal audit function.
More informationComments on Use of Databases for Establishing the Clinical Relevance of Human Genetic Variants
Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Rm. 1061 Rockville, MD 20852 The American Society of Human Genetics 9650 Rockville Pike Bethesda, MD 20814 24 December
More informationBIOVIGILANCE IN THE UNITED STATES: Regulatory Perspective
BIOVIGILANCE IN THE UNITED STATES: Regulatory Perspective Alan E. Williams, Ph.D. Office of Blood Research and Review Center for Biologics Evaluation and Research US Food and Drug Administration 15th International
More informationPatient-focused Benefit-Risk Assessment
Patient-focused Benefit-Risk Assessment March 4, 2016 NIH HCS Collaboratory and PCORnet Grand Rounds Bennett Levitan, MD-PhD Department of Epidemiology Janssen Research & Development, LLC 1 2 3 4 physician
More informationThe Future of HealthCare Information Technology
HST.921 / HST.922 Information Technology in the Health Care System of the Future, Spring 2009 Harvard-MIT Division of Health Sciences and Technology Course Directors: Dr. Steven Locke, Dr. Bryan Bergeron,
More informationFirst Do No Harm: Regulation and Clinical Integration of DTC Genetic Testing
First Do No Harm: Regulation and Clinical Integration of DTC Genetic Testing Amy L. McGuire, JD, PhD Center for Medical Ethics and Health Policy Baylor College of Medicine DTC Advertising Personal Genome
More informationBIOMEDICAL RESEARCH CENTRES
Introduction BIOMEDICAL RESEARCH CENTRES The vision of the National Institute for Health Research (NIHR) is to improve the health and wealth of the nation through research. This document sets out how the
More informationDoing Human Subjects Research? Changing NIH Policies May Impact You
Doing Human Subjects Research? Changing NIH Policies May Impact You Reforms & Initiatives To enhance the stewardship of research involving human subjects, NIH is implementing the following: All Research
More informationInnovative Pharmaceutical Solutions for Discovery Chemistry, Biology and cgmp Manufacturing
Innovative Pharmaceutical Solutions for Discovery Chemistry, Biology and cgmp Manufacturing Overview Serving biotech and pharma community since 1998 Proven track record of advancing small molecules from
More informationBBMRI.NL A story of Sharing Eline Slagboom Molecular Epidemiology, Leiden University Medical Center Brussel 20 Juni 2017
BBMRI.NL A story of Sharing Eline Slagboom Molecular Epidemiology, Leiden University Medical Center Brussel 20 Juni 2017 BBMRI-NL TOWARDS A NATIONAL BIOBANKING INFRASTRUCTURE Founded in 2009 as the Dutch
More informationNew York University Institutional Biosafety Policy Updated 08/03/2015
New York University Institutional Biosafety Policy Updated 08/03/2015 New York University and its School of Medicine and College of Dentistry are committed to ensuring that the performance of basic and
More informationEthics Committees/IRBs Today: Challenges for Efficiency and Quality
Marjorie A. Speers, Ph.D. President and CEO Ethics Committees/IRBs Today: Challenges for Efficiency and Quality Copyright 2013 AAHRPP All rights reserved Goal Clinical Research Globally Access to patients
More informationDefinitions and Acronyms
Definitions and Acronyms 510(k) A particular FDA Class For Medical Devices AE Adverse Event CFR Code of Federal Regulations CMS United States Center/College for Medicare and Medicaid Services CRA Clinical
More informationNot My Study Challenges of Clinical Trial Disclosure at an Academic Medical Center
Not My Study Challenges of Clinical Trial Disclosure at an Academic Medical Center Office of Research Compliance and Quality Assurance Yolanda P. Davis Sr. Research Compliance Officer Author: Yolanda P.
More informationThe Integrated Biomedical Sciences Graduate Program
The Integrated Biomedical Sciences Graduate Program at the university of notre dame Cutting-edge biomedical research and training that transcends traditional departmental and disciplinary boundaries to
More informationGenetics module. DNA Structure, Replication. The Genetic Code; Transcription and Translation. Principles of Heredity; Gene Mapping
Genetics module Lectures DNA Structure, Replication The Genetic Code; Transcription and Translation Principles of Heredity; Gene Mapping Controlling Gene Expression Mutation and Cancer Textbook: Introduction
More information